期刊
INFECTION AND CHEMOTHERAPY
卷 49, 期 3, 页码 243-246出版社
KOREAN SOC CHEMOTHERAPY
DOI: 10.3947/ic.2017.49.3.243
关键词
Human immunodeficiency virus; Preexposure prophylaxis; Prevention; Antiretroviral treatment
There are several guidelines for the use of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) which are used in other countries. However, the implementation of such guidelines in each country should be modified according to the country's clinical and epidemiological situation. Therefore, The Korean Society for AIDS founded a committee in 2016 to develop guidelines for the use of PrEP for HIV that are optimal for Korea's clinical and epidemiological situation. These guidelines aim to provide comprehensive information for PrEP implementation in Korea. The recommendations contain important information for physicians working to prevent HIV infection in actual clinical fields. The committee will regularly review and revise the guidelines based on changes in PrEP administration and HIV prevention practices.
推荐
暂无数据